Downregulation of CIP2A inhibits cancer cell proliferation and vascularization in renal clear cell carcinoma

Background: CIP2A has been proved to play a role as an oncogene in various types of malignancies while its functionality in renal clear cell carcinoma has not been investigated. Our study aimed to investigate the role of CIP2A in renal clear cell carcinoma and to explore the possible mechanisms. Met...

Full description

Bibliographic Details
Main Authors: Hui Gao, Yuqiao Li, Tao Lin, Yan Cheng, Yunbo Ma
Format: Article
Language:English
Published: Palacký University Olomouc, Faculty of Medicine and Dentistry 2020-06-01
Series:Biomedical Papers
Subjects:
Online Access:https://biomed.papers.upol.cz/artkey/bio-202002-0012_downregulation-of-cip2a-inhibits-cancer-cell-proliferation-and-vascularization-in-renal-clear-cell-carcinoma.php
_version_ 1828485038575976448
author Hui Gao
Yuqiao Li
Tao Lin
Yan Cheng
Yunbo Ma
author_facet Hui Gao
Yuqiao Li
Tao Lin
Yan Cheng
Yunbo Ma
author_sort Hui Gao
collection DOAJ
description Background: CIP2A has been proved to play a role as an oncogene in various types of malignancies while its functionality in renal clear cell carcinoma has not been investigated. Our study aimed to investigate the role of CIP2A in renal clear cell carcinoma and to explore the possible mechanisms. Methods: A total of 80 patients with renal clear cell carcinoma and 32 healthy people were included in the study. Expression of CIP2A was detected by qRT-PCR. CIP2A silencing renal clear cell carcinoma cell line was established. Its effects on cell proliferation and migration were verified by CCK-8 assay and Transwell cell assay, respectively. The effects of CIP2A overexpression on AKT and VEGF were investigated. Results: CIP2A expression level was increased in tumor tissues compared to adjacent healthy tissues. Serum levels of CIP2A protein were higher in cancer patients than in healthy controls, and serum levels of CIP2A protein were increased with increased stage of primary tumor. Serum CIP2A protein can be used to accurately predict renal clear cell carcinoma and its prognosis. CIP2A siRNA silencing inhibited tumor cell proliferation, and treatment with Akt activator reduced this inhibitory effect. CIP2A siRNA silencing decreased the expression level of VEGF and phosphorylation levels of AKT in renal clear cell carcinoma cells, while AKT activator treatment showed no significant effects on CIP2A expression. Conclusion: Downregulation of CIP2A can inhibit cancer cell proliferation and vascularization in renal clear cell carcinoma through inactivation of the Akt pathway and its downstream VEGF.
first_indexed 2024-12-11T09:05:52Z
format Article
id doaj.art-dede3de54485441496f5f41df202cd22
institution Directory Open Access Journal
issn 1213-8118
1804-7521
language English
last_indexed 2024-12-11T09:05:52Z
publishDate 2020-06-01
publisher Palacký University Olomouc, Faculty of Medicine and Dentistry
record_format Article
series Biomedical Papers
spelling doaj.art-dede3de54485441496f5f41df202cd222022-12-22T01:13:38ZengPalacký University Olomouc, Faculty of Medicine and DentistryBiomedical Papers1213-81181804-75212020-06-01164219620210.5507/bp.2019.031bio-202002-0012Downregulation of CIP2A inhibits cancer cell proliferation and vascularization in renal clear cell carcinomaHui Gao0Yuqiao Li1Tao Lin2Yan Cheng3Yunbo Ma4Department of Urology, Liaocheng People's Hospital, Liaocheng City, Shandong Province, P. R. China, 252000Department of Urology, Liaocheng People's Hospital, Liaocheng City, Shandong Province, P. R. China, 252000Department of Urology, Liaocheng People's Hospital, Liaocheng City, Shandong Province, P. R. China, 252000Department of Urology, Liaocheng People's Hospital, Liaocheng City, Shandong Province, P. R. China, 252000Department of Urology, Liaocheng People's Hospital, Liaocheng City, Shandong Province, P. R. China, 252000Background: CIP2A has been proved to play a role as an oncogene in various types of malignancies while its functionality in renal clear cell carcinoma has not been investigated. Our study aimed to investigate the role of CIP2A in renal clear cell carcinoma and to explore the possible mechanisms. Methods: A total of 80 patients with renal clear cell carcinoma and 32 healthy people were included in the study. Expression of CIP2A was detected by qRT-PCR. CIP2A silencing renal clear cell carcinoma cell line was established. Its effects on cell proliferation and migration were verified by CCK-8 assay and Transwell cell assay, respectively. The effects of CIP2A overexpression on AKT and VEGF were investigated. Results: CIP2A expression level was increased in tumor tissues compared to adjacent healthy tissues. Serum levels of CIP2A protein were higher in cancer patients than in healthy controls, and serum levels of CIP2A protein were increased with increased stage of primary tumor. Serum CIP2A protein can be used to accurately predict renal clear cell carcinoma and its prognosis. CIP2A siRNA silencing inhibited tumor cell proliferation, and treatment with Akt activator reduced this inhibitory effect. CIP2A siRNA silencing decreased the expression level of VEGF and phosphorylation levels of AKT in renal clear cell carcinoma cells, while AKT activator treatment showed no significant effects on CIP2A expression. Conclusion: Downregulation of CIP2A can inhibit cancer cell proliferation and vascularization in renal clear cell carcinoma through inactivation of the Akt pathway and its downstream VEGF.https://biomed.papers.upol.cz/artkey/bio-202002-0012_downregulation-of-cip2a-inhibits-cancer-cell-proliferation-and-vascularization-in-renal-clear-cell-carcinoma.phprenal clear cell carcinomacip2aaktvegf
spellingShingle Hui Gao
Yuqiao Li
Tao Lin
Yan Cheng
Yunbo Ma
Downregulation of CIP2A inhibits cancer cell proliferation and vascularization in renal clear cell carcinoma
Biomedical Papers
renal clear cell carcinoma
cip2a
akt
vegf
title Downregulation of CIP2A inhibits cancer cell proliferation and vascularization in renal clear cell carcinoma
title_full Downregulation of CIP2A inhibits cancer cell proliferation and vascularization in renal clear cell carcinoma
title_fullStr Downregulation of CIP2A inhibits cancer cell proliferation and vascularization in renal clear cell carcinoma
title_full_unstemmed Downregulation of CIP2A inhibits cancer cell proliferation and vascularization in renal clear cell carcinoma
title_short Downregulation of CIP2A inhibits cancer cell proliferation and vascularization in renal clear cell carcinoma
title_sort downregulation of cip2a inhibits cancer cell proliferation and vascularization in renal clear cell carcinoma
topic renal clear cell carcinoma
cip2a
akt
vegf
url https://biomed.papers.upol.cz/artkey/bio-202002-0012_downregulation-of-cip2a-inhibits-cancer-cell-proliferation-and-vascularization-in-renal-clear-cell-carcinoma.php
work_keys_str_mv AT huigao downregulationofcip2ainhibitscancercellproliferationandvascularizationinrenalclearcellcarcinoma
AT yuqiaoli downregulationofcip2ainhibitscancercellproliferationandvascularizationinrenalclearcellcarcinoma
AT taolin downregulationofcip2ainhibitscancercellproliferationandvascularizationinrenalclearcellcarcinoma
AT yancheng downregulationofcip2ainhibitscancercellproliferationandvascularizationinrenalclearcellcarcinoma
AT yunboma downregulationofcip2ainhibitscancercellproliferationandvascularizationinrenalclearcellcarcinoma